Skip to main content

Liquid-based Rapid Onsite Evaluation of Endobronchial Ultrasound Cytologies

Tracking # 20-1085970

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

The eJournal is an online pathology journal club that reviews current articles from a peer-reviewed cytopathology Journal. Participants will be able to review the journal article, commentary and webinar from the contributing author. This is a great self-assessment, teaching and continuing education tool. TARGET AUDIENCE This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community. LEARNING OBJECTIVES To understand the value of Rapid Onsite Evaluation (ROSE) To understand the challenges of ROSE To understand the concept of "liquid-based" and the rapid staining processes used in this study To be able to describe the advantages of liquid-based ROSE over smear-based ROSE To be able to describe limitations of liquid-based ROSE compared to smear-based ROSE Presenter(s): Nicole Anderson, MD Andrew Fischer, MD Shi Bai, MD, PhD

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General (Cytology)

Clinical Laboratory Supervisor

1h General (Cytology)

Clinical Laboratory Technician

1h General (Cytology)

Clinical Laboratory Technologist

1h General (Cytology)

Public Health Director

1h General (Cytology)

Public Health Supervisor

1h General (Cytology)

Public Health Technologist

1h General (Cytology)

Disclosure statements

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:

Oscar Lin MD PhD: Consultant – Hologic and Jansen

Liron Pantanowitz MD: Consultant – Hamamatsu, Advisory Board for Ibex

Martha B Pitman MD FIAC: Consultant – Adenocyte, LLC

Donna K. Russell MEd CT(ASCP) HT(ASCP): Advisory Board – Hologic Scientific

Christopher J. VandenBussche MD PhD: Ad hoc advisory board panel and Consultant – Roche

Andrew Fischer, MD: Royalties for sales of Cellient technology - Hologic

The following individuals have reported no relevant financial relationships:

Susan A. Alperstein, MS, CT(ASCP), Fatima Z. Aly, MD, PhD, Tatjana Antic, MD, Kristen A. Atkins, MD, Guliz A. Barkan, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Aastha Chauhan, MD, Jeanine M. Chiaffarano, DO, Paul Z. Chiou, MPH, SCT(ASCP), Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Kara L. Hansing, MEd, SCT(ASCP)CM, Melissa Hogan, MD, Seema Khutti, MBBS, Xiaoqi Lin, MD, PhD, Patrick McIntire, MD, Sanjana Mehrotra, MD, Sara E. Monaco, MD, Seyedreza Mousavi, MD, MS, Ranjana S. Nawgiri, MD, M. Katayoon Rezaei, MD, Esther D. Rossi, MD, PhD, Sinchita Roy-Chowdhuri, MD, PhD, Sadia Sayeed, MD, Momin T. Siddiqui, MD, FIAC, Swikrity Upadhyay Baskota, MD, Saloni Walia, MD, Nicole Anderson, MD, Shi Bai, MD

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.